Paul M. Moseley

Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer

Tarek M. Abdel-Fatah, Roslin Russell, Nada Albarakati et al. · Molecular Oncology · 2014 · 147 citations · Full text

SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

Tarek M.A. Abdel-Fatah, Devika Agarwal, Dongxu Liu et al. · The Lancet Oncology · 2016 · 102 citations · Full text

Prognostic Biomarkers, Breast Oncology, Oncology +11

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

T. M. A. Abdel-Fatah, Christina J. Perry, P. Dickinson et al. · Annals of Oncology · 2013 · 85 citations · Full text

Breast Oncology, Oncology, Independent Prognostic Marker +7

Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora et al. · Molecular Oncology · 2014 · 84 citations · Full text

Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells

Rebeka Sultana, Tarek M.A. Abdel-Fatah, Christina J. Perry et al. · PLoS ONE · 2013 · 83 citations · Full text